danazol has been researched along with Disease Exacerbation in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Advani, A; Barot, SV; Carraway, HE; Kalaycio, M; Kerr, C; Kuzmanovic, T; Lee, S; Lichtin, A; Maciejewski, JP; Patel, BJ; Patel, S; Przychodzen, BP; Radivoyevitch, T; Sekeres, MA; Thota, S | 1 |
| Abish, S; Ali, SS; Breakey, VR; Brossard, J; Cada, M; Català, A; Corriveau-Bourque, C; Cuvelier, GDE; Dror, Y; Fernandez, CV; Goodyear, L; Jardine, L; Klaassen, RJ; Lauhasurayotin, S; Lipton, JH; Michon, B; Pastore, YD; Rayar, M; Silva, M; Sinha, R; Steele, M; Sung, L; Zlateska, B | 1 |
| Cervenak, L; Farkas, H; Kajdácsi, E; Karádi, I; Kőhalmi, KV; Nebenführer, Z; Szabó, E; Zsáry, A | 1 |
| Bygum, A | 1 |
| Ciccolini, A; Dror, Y; Zlateska, B | 1 |
| Aylı, M; Cengiz Seval, G; Özcan, M | 1 |
| Csuka, D; Czaller, I; Farkas, H; Imreh, É; Takács, E; Varga, L; Veszeli, N; Zotter, Z | 1 |
| Biswal, N; Chandar, R; Chandrasekaran, V; Jagadisan, B; Kumar, D | 1 |
| Birjmohun, RS; Dallinga-Thie, GM; Hofstra, JJ; Kastelein, JJ; Kees Hovingh, G; Levi, M; Meijers, JC; Stroes, ES | 1 |
| Fu, R; Li, H; Wang, H; Yang, R; Zhang, L; Zhou, F; Zhou, H; Zhou, Z | 1 |
| Provan, D; Stasi, R | 1 |
| Ahn, ER; Ahn, YS; Donna, E; Dudkiewicz, P; Fontana, V; Horstman, LL | 1 |
| Hamada, K; Ichijima, K; Kasuga, H; Kobayashi, H; Mishima, K; Nakaya, M; Narita, N; Shirayama, R | 1 |
| Cosson, A; Fenaux, P; Grardel, N; Lepelley, P; Poulain, S; Preudhomme, C | 1 |
| Bauters, F; Bourgeois, E; Caulier, MT; Dupriez, B; Fenaux, P; Rose, C | 1 |
2 review(s) available for danazol and Disease Exacerbation
| Article | Year |
|---|---|
Hemophagocytic Lymphohistiocytosis in A Child With Very Severe Aplastic Anemia: Double Jeopardy Resulting in Fatality.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Child; Danazol; Delayed Diagnosis; Diagnostic Errors; Disease Progression; Drug Resistance; Fatal Outcome; Febrile Neutropenia; Hepatomegaly; Humans; Immunosuppressive Agents; Iron Overload; Lymphohistiocytosis, Hemophagocytic; Male; Splenomegaly | 2017 |
Management of immune thrombocytopenic purpura in adults.
Topics: Adult; Age Factors; Alemtuzumab; Algorithms; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Child; Danazol; Decision Trees; Disease Progression; Emergency Treatment; Estrogen Antagonists; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Incidence; Male; Patient Selection; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Rho(D) Immune Globulin; Rituximab; Splenectomy | 2004 |
2 trial(s) available for danazol and Disease Exacerbation
| Article | Year |
|---|---|
Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Topics: Adult; Angioedemas, Hereditary; Apolipoprotein A-I; Atherosclerosis; Blood Coagulation; Carotid Arteries; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cross-Over Studies; Cross-Sectional Studies; Danazol; Disease Progression; Female; Humans; Lipoproteins; Male; Middle Aged; Surveys and Questionnaires; Testosterone Congeners; Time Factors; Triglycerides; Tunica Intima | 2008 |
Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Danazol; Disease Progression; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation; Hematopoietic Stem Cells; Humans; Karyotyping; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Life Tables; Myelodysplastic Syndromes; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Quinine; Survival Analysis; Treatment Outcome; Tumor Suppressor Protein p53; Vault Ribonucleoprotein Particles | 1998 |
11 other study(ies) available for danazol and Disease Exacerbation
| Article | Year |
|---|---|
Distinctive and common features of moderate aplastic anaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Anemia, Aplastic; Autoimmune Diseases; Benzoates; Blood Transfusion; Bone Marrow; Child; Child, Preschool; Clonal Evolution; Combined Modality Therapy; Danazol; Disease Management; Disease Progression; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hemoglobinuria, Paroxysmal; Humans; Hydrazines; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Pyrazoles; Severity of Illness Index; Young Adult | 2020 |
Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry.
Topics: Adolescent; Adult; Androgens; Bone Marrow Failure Disorders; Canada; Cell Lineage; Child; Child, Preschool; Combined Modality Therapy; Danazol; Disease Progression; Drug Substitution; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Oxymetholone; Pancytopenia; Registries; Thrombocytopenia; Treatment Outcome; Virilism | 2020 |
Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
Topics: Adult; Atherosclerosis; Bradykinin; Case-Control Studies; Complement C1 Inhibitor Protein; Danazol; Disease Progression; Endothelial Cells; Endothelium, Vascular; Estrogen Antagonists; Female; Hereditary Angioedema Types I and II; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Surveys and Questionnaires; Vasodilation; Young Adult | 2019 |
Hereditary angioedema - consequences of a new treatment paradigm in Denmark.
Topics: Activities of Daily Living; Administration, Cutaneous; Adult; Aged; Angioedemas, Hereditary; Bradykinin; Complement C1 Inhibitor Protein; Cost of Illness; Danazol; Denmark; Dermatologic Agents; Disease Progression; Drug Administration Schedule; Female; Home Care Services; Hospitalization; Humans; Male; Middle Aged; Motor Activity; Prospective Studies; Quality of Life; Registries; Time Factors; Tranexamic Acid; Treatment Outcome | 2014 |
Treatment of dyskeratosis congenita-associated pulmonary fibrosis with danazol.
Topics: Adolescent; Danazol; Disease Progression; Dyskeratosis Congenita; Estrogen Antagonists; Female; Humans; Mutation; Pulmonary Fibrosis; Telomere; Telomere-Binding Proteins | 2015 |
Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report.
Topics: Aged; Aspergillosis; Blood Transfusion; Danazol; Disease Progression; Drug Resistance; Fatal Outcome; Humans; Hydroxyurea; Janus Kinase 2; Lenalidomide; Leukemia, Myeloid, Acute; Male; Nitriles; Primary Myelofibrosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Splenectomy; Splenic Infarction; Thalidomide | 2015 |
Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Biomarkers; Case-Control Studies; Complement C1 Inhibitor Protein; Complement C4; Complement System Proteins; Danazol; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hereditary Angioedema Types I and II; Humans; Male; Middle Aged; Thyroid Hormones; Young Adult | 2016 |
Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Murine-Derived; China; Comorbidity; Danazol; Disease Progression; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; Hemorrhage; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Remission, Spontaneous; Retrospective Studies; Rituximab; Treatment Outcome | 2013 |
Interstitial lung disease (ILD) and severe ITP.
Topics: Aged; Biopsy; Blood Platelets; Chronic Disease; Danazol; Diagnosis, Differential; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Inflammation; Lung Diseases, Interstitial; Male; Middle Aged; Pneumonia; Pulmonary Fibrosis; Purpura, Thrombocytopenic, Idiopathic; Radiography | 2007 |
[Autopsy findings of retroperitoneal cystic tumor and peliosis hepatis in lymphangiomyomatosis].
Topics: Danazol; Disease Progression; Estrogen Antagonists; Female; Humans; Lung Neoplasms; Lymphangioleiomyomatosis; Middle Aged; Peliosis Hepatis; Respiratory Insufficiency; Retroperitoneal Neoplasms | 1997 |
Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Blood Platelets; Cellular Senescence; Cerebral Hemorrhage; Combined Modality Therapy; Danazol; Disease Progression; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Interleukin-3; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Platelet Count; Recurrence; Retrospective Studies; Sjogren's Syndrome; Splenectomy; Thrombocytopenia; Treatment Outcome; Treatment Refusal; Vasculitis | 2001 |